Lacosamide (All indications)

Table   Graphic  
individual studies
OutcomeTE95% CIn casesn exposedkPub. bias Congenital malformations All congenital malformations (majors, minors, majors and minors, or unspecified) Tomson (Lacosamide), 2018 The NAAED (Controls unexposed, disease free) (Indications NOS), 2022 21.27[0.17; 9.56]8672not evaluable Major congenital malformations Tomson (Lacosamide), 2018 The NAAED (Controls unexposed, disease free) (Indications NOS), 2022 21.27[0.17; 9.56]8672not evaluable0.010.01.0